Osteosarcoma research

The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development. These, and other factors, contribute to unsustainable costs and longer timelines before much-needed therapies reach the market.

Characterization of residual impurities for gene therapy drug products is particularly challenging due to the complex nature of the final products as well as the complicated processes required to manufacture them.

Join us in advancing basic biology and recent tools and techniques in cell research by coming together with like-minded colleagues. Cell Biology 2017 creates a valuable platform for inspiring global and interdisciplinary collaboration in a virtual environment. The Conference will bring together professors, post-docs, biologists and biomedical professionals from all over the world. Attend interactive sessions, first-class exhibitions and virtual poster presentations. A cell is the smallest individual unit of any living organism. Cell biology studies cells – their physiological properties, structure, the organelles they contain, environmental interactions, life cycle, division and death, on a microscopic and molecular level.

Dramatic responses observed with targeted agents in the ‘right’ genomic context have fueled large scale sequencing efforts to identify ‘effective’ treatments for a given patient. In order to expeditiously evaluate a targeted agent against a potential ‘driver’ genetic aberration, so-called Basket trials are conducted.